罕见但相关:甲基胺和帕金森病
1National Drug and Alcohol Research Centre (NDARC), University of New South Wales, Sydney, Australia.
Addiction (Abingdon, England)
|October 22, 2024
概括
甲胺使用会增加患帕金森病 (PD) 和帕金森症的风险. 然而,由于死亡率和吸烟等因素,PD在使用者中被诊断不足,需要临床警.
科学领域:
- 神经科学是一个神经科学.
- 毒理学 毒理学 毒理学
- 流行病学 流行病学
背景情况:
- 甲基胺 (MA) 的使用与帕金森病 (PD) 和帕金森症的更高风险有关.
- 动物研究表明,支持这种关联的生物机制.
- 现在和以前的MA使用者中,PD和帕金森病的患病率较高.
研究的目的:
- 探索甲基胺使用与帕金森病之间的关系.
- 调查甲基胺使用者的PD诊断不足的原因.
主要方法:
- 审查来自各种研究范式的现有证据.
- 在甲基胺使用者群体中分析流行数据.
- 考虑潜在的缓解因素和生物可信性.
主要成果:
- 甲基胺使用与PD和帕金森症的风险增加和早发症有关.
- 在甲基胺使用者中,PD是很少被诊断出来的,这表明没有被检测到.
- 过早死亡率,吸烟和其他个体特征等因素可能会影响风险和检测.
结论:
- 临床医生必须在甲基胺使用者中保持对PD和帕金森症的高度怀疑指数.
- 需要进一步的研究,以了解影响PD诊断因素的复杂相互作用.
相关概念视频
Parkinson's Disease: Treatment
227
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
227
Parkinson's Disease: Overview
486
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
486
Drugs Affecting Neurotransmitter Synthesis
1.3K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.3K
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
165
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
165
Neural Regulation
39.1K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.1K
Drug Abuse and Addiction: Pharmacological Phenomena
445
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
445


